Article ID Journal Published Year Pages File Type
8813515 Pediatrics & Neonatology 2017 9 Pages PDF
Abstract
EPO administration did not significantly increase the risk of ROP of any stage reported or Stage ≥3. Further clinical trials investigating the impact of EPO on ROP in premature infants should include all confounding factors to clarify this important issue.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Perinatology, Pediatrics and Child Health
Preview
Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants
Authors
, , , ,